Jun Sugisaka

Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

Yukihiro Toi, Shunichi Sugawara, Jun Sugisaka et al. · JAMA Oncology · 2018 · 360 citations · Full text

Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab

Yukihiro Toi, Shunichi Sugawara, Yosuke Kawashima et al. · The Oncologist · 2018 · 289 citations · Full text

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H. Owen et al. · Cancer Immunology Immunotherapy · 2020 · 93 citations · Full text

Cancer Epidemiology, Pooled Exploratory Analysis, Medicine +8

CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion

Yasushi Sasaki, Ryota Koyama, Reo Maruyama et al. · Cancer Biology & Therapy · 2012 · 59 citations · Full text

Cancer Cell Migration, Focal Adhesion Kinase, Cell Regulation +15

Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer

Mari Aso, Yukihiro Toi, Jun Sugisaka et al. · The Oncologist · 2019 · 56 citations · Full text